Blue Sail Medical Co.,Ltd. (SHE:002382)
China · Delayed Price · Currency is CNY 6.32
+0.22 (3.61%)
Sep 30, 2026, 3:04 PM CST
Blue Sail Medical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 6,333 | 5,609 | 5,138 | 6,727 | 7,845 | 16,405 | |
Market Cap Growth | 13.93% | 9.16% | -23.62% | -14.25% | -52.18% | -19.31% |
Enterprise Value | 10,336 | 9,995 | 7,723 | 8,723 | 8,351 | 16,070 |
Last Close Price | 6.32 | 5.60 | 5.13 | 6.68 | 7.39 | 15.45 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | - | - | - | 14.20 |
Forward PE | - | 4.41 | 4.41 | 4.41 | 4.41 | 5.08 |
PS Ratio | 0.96 | 0.98 | 0.82 | 1.37 | 1.60 | 2.02 |
PB Ratio | 0.67 | 0.59 | 0.51 | 0.71 | 0.74 | 1.56 |
P/TBV Ratio | 2.82 | 2.69 | 1.55 | 1.46 | 1.39 | 2.68 |
P/OCF Ratio | 12.03 | 12.25 | 37.82 | - | 15.87 | 7.31 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 1.57 | 1.74 | 1.24 | 1.77 | 1.70 | 1.98 |
EV/EBITDA Ratio | 12.48 | 41.08 | 26.67 | - | - | 5.81 |
EV/EBIT Ratio | 38.37 | - | - | - | - | 6.57 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.34 | 0.55 | 0.49 | 0.42 | 0.30 | 0.35 |
Debt / EBITDA Ratio | 3.85 | 20.09 | 16.31 | - | - | 1.34 |
Net Debt / Equity Ratio | 0.17 | 0.24 | 0.24 | 0.26 | 0.07 | -0.02 |
Net Debt / EBITDA Ratio | 2.00 | 9.36 | 8.27 | -29.05 | -3.41 | -0.09 |
Net Debt / FCF Ratio | 9.22 | -23.91 | -3.75 | -2.89 | -1.70 | 0.74 |
Asset Turnover | 0.41 | 0.34 | 0.38 | 0.31 | 0.30 | 0.48 |
Inventory Turnover | 4.46 | 4.19 | 4.61 | 4.46 | 4.39 | 4.63 |
Quick Ratio | 0.64 | 0.64 | 1.31 | 0.66 | 1.48 | 1.53 |
Current Ratio | 0.91 | 0.85 | 1.79 | 0.96 | 1.94 | 1.99 |
Return on Equity (ROE) | -4.90% | -8.18% | -4.74% | -5.66% | -3.53% | 11.36% |
Return on Assets (ROA) | 1.04% | -1.15% | -0.84% | -2.35% | -2.57% | 9.01% |
Return on Invested Capital (ROIC) | 2.34% | -2.58% | -1.81% | -5.09% | -6.26% | 20.30% |
Return on Capital Employed (ROCE) | 2.60% | -3.00% | -1.60% | -5.00% | -5.00% | 17.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | -8.58% | -13.53% | -8.67% | -8.45% | -4.75% | 7.04% |
FCF Yield | 2.78% | -1.70% | -12.43% | -12.59% | -5.13% | -2.05% |
Dividend Yield | - | - | - | - | 5.41% | - |
Payout Ratio | - | - | - | - | - | 41.29% |
Buyback Yield / Dilution | 3.48% | 1.40% | 0.21% | -0.86% | 4.22% | -3.36% |
Total Shareholder Return | 3.48% | 1.40% | 0.21% | -0.86% | 9.64% | -3.36% |